Literature DB >> 24973449

Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming.

Sandra Hervas-Stubbs1, Jose-Ignacio Riezu-Boj2, Uxua Mancheño2, Paloma Rueda3, Lissette Lopez3, Diego Alignani2, Estefanía Rodríguez-García2, Nathalie Thieblemont4, Claude Leclerc5.   

Abstract

Plasmacytoid dendritic cells (pDCs) are considered to be the principal type-I IFN (IFN-I) source in response to viruses, whereas the contribution of conventional DCs (cDCs) has been underestimated because, on a per-cell basis, they are not considered professional IFN-I-producing cells. We have investigated their respective roles in the IFN-I response required for CTL activation. Using a nonreplicative virus, baculovirus, we show that despite the high IFN-I-producing abilities of pDCs, in vivo cDCs but not pDCs are the pivotal IFN-I producers upon viral injection, as demonstrated by selective pDC or cDC depletion. The pathway involved in the virus-triggered IFN-I response is dependent on TLR9/MyD88 in pDCs and on stimulator of IFN genes (STING) in cDCs. Importantly, STING is the key molecule for the systemic baculovirus-induced IFN-I response required for CTL priming. The supremacy of cDCs over pDCs in fostering the IFN-I response required for CTL activation was also verified in the lymphocytic choriomeningitis virus model, in which IFN-β promoter stimulator 1 plays the role of STING. However, when the TLR-independent virus-triggered IFN-I production is impaired, the pDC-induced IFNs-I have a primary impact on CTL activation, as shown by the detrimental effect of pDC depletion and IFN-I signaling blockade on the residual lymphocytic choriomeningitis virus-triggered CTL response detected in IFN-β promoter stimulator 1(-/-) mice. Our findings reveal that cDCs play a major role in the TLR-independent virus-triggered IFN-I production required for CTL priming, whereas pDC-induced IFNs-I are dispensable but become relevant when the TLR-independent IFN-I response is impaired.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973449      PMCID: PMC4105236          DOI: 10.4049/jimmunol.1301440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Unresponsiveness of MyD88-deficient mice to endotoxin.

Authors:  T Kawai; O Adachi; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

Review 2.  Activation of dendritic cells: translating innate into adaptive immunity.

Authors:  Caetano Reis e Sousa
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

3.  Toll-like receptor ligands directly promote activated CD4+ T cell survival.

Authors:  Andrew E Gelman; Jidong Zhang; Yongwon Choi; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 4.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

Authors:  Yong-Jun Liu
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.

Authors:  Florence Boisgérault; Paloma Rueda; Cheng Ming Sun; Sandra Hervas-Stubbs; Marie Rojas; Claude Leclerc
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

6.  Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody.

Authors:  Carine Asselin-Paturel; Géraldine Brizard; Jean-Jacques Pin; Francine Brière; Giorgio Trinchieri
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

7.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.

Authors:  Anne Krug; Anthony R French; Winfried Barchet; Jens A A Fischer; Andrzej Dzionek; Jeanette T Pingel; Michael M Orihuela; Shizuo Akira; Wayne M Yokoyama; Marco Colonna
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

8.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

Authors:  Sandra S Diebold; Maria Montoya; Hermann Unger; Lena Alexopoulou; Polly Roy; Linsey E Haswell; Aymen Al-Shamkhani; Richard Flavell; Persephone Borrow; Caetano Reis e Sousa
Journal:  Nature       Date:  2003-06-22       Impact factor: 49.962

9.  Plasmacytoid dendritic cells are dispensable during primary influenza virus infection.

Authors:  Amaya I Wolf; Darya Buehler; Scott E Hensley; Lois L Cavanagh; E John Wherry; Philippe Kastner; Susan Chan; Wolfgang Weninger
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.

Authors:  Géraldine Schlecht; Sylvie Garcia; Nicolas Escriou; Antonio A Freitas; Claude Leclerc; Gilles Dadaglio
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113

View more
  12 in total

1.  Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition.

Authors:  Rosana Gonzalez-Quintial; Jessica M Mayeux; Dwight H Kono; Argyrios N Theofilopoulos; Kenneth M Pollard; Roberto Baccala
Journal:  Clin Immunol       Date:  2019-06-05       Impact factor: 3.969

2.  Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses.

Authors:  Céline Cousin; Marine Oberkampf; Tristan Felix; Pierre Rosenbaum; Robert Weil; Sylvie Fabrega; Valeria Morante; Donatella Negri; Andrea Cara; Gilles Dadaglio; Claude Leclerc
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

3.  Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.

Authors:  Sabrina Amalfi; Guido Nicolás Molina; Romina Jimena Bevacqua; María Gabriela López; Oscar Taboga; Victoria Alfonso
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

4.  Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways.

Authors:  Derek J Royer; Christopher D Conrady; Daniel J J Carr
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

5.  High-throughput quantitative real-time RT-PCR assay for determining expression profiles of types I and III interferon subtypes.

Authors:  Lynnsey A Renn; Terence C Theisen; Maria B Navarro; Viraj P Mane; Lynnsie M Schramm; Kevin D Kirschman; Giulia Fabozzi; Philippa Hillyer; Montserrat Puig; Daniela Verthelyi; Ronald L Rabin
Journal:  J Vis Exp       Date:  2015-03-24       Impact factor: 1.355

6.  Routing cancer immunology and immunotherapy from the lab to the clinic 4-5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain.

Authors:  M Ángela Aznar; Ignacio Melero; José I Quetglas
Journal:  J Transl Med       Date:  2014-07-24       Impact factor: 5.531

7.  Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny.

Authors:  Guido N Molina; Eugenia Tavarone; Oscar Taboga; Paula Molinari
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

8.  MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.

Authors:  Shuhui Liu; Kaitao Zhao; Xi Su; Lu Lu; He Zhao; Xianwen Zhang; Yun Wang; Chunchen Wu; Jizheng Chen; Yuan Zhou; Xue Hu; Yanyi Wang; Mengji Lu; Xinwen Chen; Rongjuan Pei
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

9.  Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.

Authors:  Justine Schaeffer; Xavier Carnec; Stéphanie Reynard; Mathieu Mateo; Caroline Picard; Natalia Pietrosemoli; Marie-Agnès Dillies; Sylvain Baize
Journal:  PLoS Pathog       Date:  2018-11-12       Impact factor: 6.823

10.  Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition.

Authors:  Rosana Gonzalez-Quintial; Anthony Nguyen; Dwight H Kono; Michael B A Oldstone; Argyrios N Theofilopoulos; Roberto Baccala
Journal:  PLoS One       Date:  2018-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.